Answers are grounded in this paper and cite their sources.
An inulin-based copolymer bearing high dose doxorubicin (18.45 % w/w), INU-EDA-P,C-DOXO, was prepared by coupling doxorubicin with inulin though citraconylamide bridge used as pH sensitive spacer. Its smart and selective anticancer effect was proved.
No takes yet. Share an insight, caveat, or question.
Mauro et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: